According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is 0,26ย โฌ. In 2024 the company made an earnings per share (EPS) of -0,88ย โฌ an increase over its 2023 EPS that were of -2,25ย โฌ.